Skip to main content

Free Content Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice

Download Article:

You have access to the full text article on a website external to Ingenta Connect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library


Sleep/wakefulness (S/W) disorders are frequent in Parkinson’s disease (PD). The underlying causes have yet to be elucidated but dopaminergic neurodegenerative lesions seem to contribute to appearance of the disorders and anti-Parkinsonian medication is known to accentuate S/W problems. Hence, we reasoned that studying the acute effect of dopaminergic compounds on S/W in an animal model of PD might improve our knowledge of S/W regulation in the context of partial dopaminergic depletion. To this end, we tested the effect of levodopa (l-dopa), pergolide (a mixed D2/D1 agonist) and lisuride (a D2 agonist) on S/W recordings in MPTP-treated mice, in comparison with controls. Our results showed that dopaminergic compounds modify S/W amounts in both control and MPTP mice. Wakefulness amounts are greater in MPTP mice afterl-dopa (50 mg kg−1) and lisuride (1 mg kg−1) injections compared with control mice. Moreover, the paradoxical sleep latency was significantly longer in MPTP mice after high-dosel-dopa administration. Our observations suggest that the actions of bothl-dopa and lisuride on S/W differ slightly in MPTP mice relative to controls. Hence, MPTP-induced partial DA depletion may modulate the effect of dopaminergic compounds on S/W regulation.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: MPTP mice; Parkinson’s disease; dopaminergic medication; sleep/wakefulness

Document Type: Research Article

Affiliations: 1: Laboratoire de Physiologie 2: Laboratoire de Pharmacologie, Institut Fédératif de Recherche, Faculté de Médecine, Pôle recherche 3: Clinique Neurologique, Hôpital R. Salengro, CHRU de Lille, Lille cedex, France

Publication date: 2008-03-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more